sPD-1 and inflammatory mediators of patients with RA significantly attenuated or reversed T-cell suppression mediated by PD-L1-Fc, verifying that sPD-1 acts as a natural blocker of PD-1/PD-L1 signaling and that soluble factors may interfere with this negative pathway. This evidence concerns the gene PDCD1 and rheumatoid arthritis.